Chevy Chase Trust Holdings, Inc. Maxcyte, Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $35.7 Billion
- Q3 2025
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 263,693 shares of MXCT stock, worth $416,634. This represents 0.0% of its overall portfolio holdings.
Number of Shares
263,693
Previous 1,723,239
84.7%
Holding current value
$416,634
Previous $3.76 Million
88.92%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
71.8MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY8.23MShares$13 Million0.78% of portfolio
-
Mirabella Financial Services LLP London, X08.2MShares$13 Million0.41% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$12.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.7MShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.59MShares$8.83 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $161M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...